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Acylphosphatase, one of the smallest enzymes, is ex-
pressed in all organisms. It displays hydrolytic activity
on acyl phosphates, nucleoside di- and triphosphates,
aryl phosphate monoesters, and polynucleotides, with
acyl phosphates being the most specific substrates in
vitro. The mechanism of catalysis for human acylphos-
phatase (the organ-common type isoenzyme) was inves-
tigated using both aryl phosphate monoesters and acyl
phosphates as substrates. The enzyme is able to catalyze
phosphotransfer from p-nitrophenyl phosphate to glyc-
erol (but not from benzoyl phosphate to glycerol), as
well as the inorganic phosphate-H2
18O oxygen exchange
reaction in the absence of carboxylic acids or phenols.
In short, our findings point to two different catalytic
pathways for aryl phosphate monoesters and acyl phos-
phates. In particular, in the aryl phosphate monoester
hydrolysis pathway, an enzyme-phosphate covalent in-
termediate is formed, whereas the hydrolysis of acyl
phosphates seems a more simple process in which the
Michaelis complex is attacked directly by a water mole-
cule generating the reaction products. The formation of
an enzyme-phosphate covalent complex is consistent
with the experiments of isotope exchange and
transphosphorylation from substrates to glycerol, as
well as with the measurements of the Brønsted free en-
ergy relationships using a panel of aryl phosphates with
different structures. His-25 involvement in the forma-
tion of the enzyme-phosphate covalent complex during
the hydrolysis of aryl phosphate monoesters finds sig-
nificant confirmation in experiments performed with
the H25Q mutated enzyme.
Acylphosphatase (ACP),1 one of the smallest enzymes (11
kDa), is expressed in all known organisms, and its cellular
function has not been hitherto fully understood. Several re-
ports indicate that ACP is involved in controlling membrane
ion pumps (Refs. 1 and 2 and citations therein) because in vitro
it displays hydrolytic activity against the aspartyl phosphate
intermediate formed during the action of membrane Na,K-
and Ca2-ATPases. The fact that ACP is able to bind sarco-/
endoplasmic reticulum calcium ATPase (3) is in line with the
preceding hypothesis. Other reports note the involvement of
ACP in cell differentiation and apoptosis (4–6); the ACP level
is greatly enhanced during the differentiation process that a
number of specific compounds (triiodothyronine, phorbol 12-
myristate 13-acetate, aphidicolin, and hemin) induce, and
moreover, the enzyme is able to migrate into the nucleus dur-
ing both differentiation and apoptosis (7, 8). The overexpres-
sion of ACP in yeast cells enhances the rate of glycolysis,
suggesting that it is capable of hydrolyzing 1,3-bisphosphoglyc-
erate in vivo (9).
Site-directed mutagenesis experiments suggest that Arg-23
and Asn-41 are essential residues (10, 11), Arg-23 being in-
volved in the binding of the substrate phosphate moiety (12). A
model based on x-ray crystallography data for the catalytic
hydrolysis of acyl phosphates by ACP was previously proposed
by Thunnissen et al. (12).
In this article we demonstrate that human CT acylphos-
phatase catalyzes the hydrolysis of aryl phosphates displaying
a different mechanism from the one it uses for acyl phosphate
hydrolysis. For p-nitrophenyl phosphate hydrolysis, we found
that the enzyme uses His-25 to perform a nucleophilic catalysis
step, which, by contrast, it does not use in the catalytic hydrol-
ysis of acyl phosphates.
EXPERIMENTAL PROCEDURES
Reagents—Benzoyl phosphate was synthesized as described previ-
ously (13). The aryl phosphate monoesters 4-cyano and 3-chloro were
synthesized as dicycloexylammonium salts in accordance with Zhang
and Van Etten (14), whereas p-nitrophenyl phosphate, phenyl phos-
phate, -naphtyl phosphate, and L-tyrosine phosphate where purchased
from Sigma. [18O]water at 97% isotope enrichment was purchased from
Cambridge Isotope Laboratories. All other reagents were the purest
commercially available grade.
Enzymes—wild-type human CT-ACP was produced and purified as
previously described (15). The H25Q mutant of CT-ACP was obtained
by oligonucleotide-directed mutagenesis using a unique site elimination
(USE) mutagenesis kit based on the USE method developed by Deng
and Nickoloff (16). The mutations were confirmed by DNA sequencing
according to Sanger et al. (17) and by amino acid analysis of the purified
proteins.
Determination of Enzyme Activity—Benzoylphosphatase activity was
assayed using a continuous optical test in accordance with Ramponi et
al. (18). The hydrolytic activity on aryl phosphates was in general
assayed as follows: substrates were dissolved in 1 ml of 0.1 M acetate
buffer, pH 5.3, containing 1 mM EDTA (Buffer 1). The mixture was
incubated at 37 °C and after the addition of the enzyme, aliquots were
taken at different times to assay the released Pi by the method of
Baginski et al. (19). The p-nitrophenyl phosphatase activity was as-
sayed at 37 °C; pNPP was dissolved in Buffer 1 at the final volume of 1
ml. The reaction was stopped by the addition of 4 ml of 0.1 M KOH, and
the released p-nitrophenolate ion was measured at 400 nm (  18,000
M1cm1).
Inorganic Phosphate-Water Medium 18O Exchange—An orthophos-
phoric acid solution (100 mM final concentration) was adjusted to pH 5.3
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with NaOH. Then, 25 l were withdrawn and transferred to a small
screw-cap conical vial and dried. The residue was dissolved in 25 l of
[18O]water, and 1 l of human CT-ACP (0.28 g/liter) was added. The
mixture was incubated at room temperature. Aliquots of 2 l were
withdrawn at varying incubation times and diluted with water to 100 l
in order to perform MS analyses. To verify the performance of the
method, a parallel experiment with calf intestine alkaline phosphatase
was carried out (in this experiment, the pH of the incubation mixture
(25 l) was adjusted to 9.0, and 0.14 units of alkaline phosphatase were
added (the unit is defined as the amount of enzyme that catalyzes the
hydrolysis of 1 mol of pNPP at 25 °C and pH 9.0)).
Mass Spectrometry—Electrospray mass spectra in negative ion mode
were obtained under the following conditions: ion spray voltage, 2.2 kV;
nozzle potential, 120 V; quadrupole DC potential, 8.5 V; quadrupole rf
potential, 350 V. Analyzer settings: push pulse potential, 770 V; pull
pulse potential, 250 V; pull bias potential, 11.5 V; acceleration poten-
tial, 4 kV; reflector potential, 1.5 kV; detector potential, 2.05 kV. Scan
range m/z, 60–300; scan rate, 8 ms/atomic mass.
RESULTS
Human CT-ACP Catalyzes the Transfer of Phosphate from
pNPP to Glycerol but Not from Benzoyl Phosphate—The ability
of ACP to catalyze phosphate transfer was verified by partition
experiments using two different substrates, pNPP and benzoyl
phosphate. Wild-type enzyme was added to Buffer 1 solution
containing pNPP or, alternatively, benzoyl phosphate either in
the presence or absence of 1 M glycerol, a nucleophile that may
compete with water in attacking the phosphorus atom of the
hypothesized E-P covalent intermediate (see Scheme 1).
At the appropriate times, aliquots of the mixtures were
drawn off, and measurements were taken of the quantities of Pi
and pNP or Pi and benzoate released. The overall rates of
substrate turnovers (hydrolysis plus substrate transfer) were
measured by the quantity of pNP or benzoate (from pNPP or
benzoyl phosphate, respectively) produced, whereas the hydrol-
ysis rates were measured by the quantity of inorganic phos-
phate produced. Table I shows that, in the absence of glycerol,
the hydrolysis rates of pNPP or benzoyl phosphate, determined
by the pNP or benzoate assays, were very close to those deter-
mined by the phosphate assays. In the presence of 1 M glycerol,
we observed an increase in pNPP but not of benzoyl phosphate
overall turnover. Table I shows the molar ratios of pNP/Pi
produced by the ACP catalysis; at pH 5.3 and 6.5 they were,
respectively, 0.97 and 0.94 in water, and 1.77 and 1.97 in 1 M
glycerol. Table I also shows the results of experiments carried
out with benzoyl phosphate; at pH 5.3, we found the benzo-
ate/Pi molar ratio in water to be 1.01 and, in the water-glycerol
mixture, 0.96, whereas at pH 6.5, we found it to be 1.0 in water
and 0.97 in 1 M glycerol.
Glycerol Interacts with and Activates ACP—On measuring
the fluorescence emission spectra of ACP at varying concentra-
tion of glycerol, we found that a higher glycerol concentration
causes both a small drop of the signal and a small red-shift of
the tryptophan emission band (Fig. 1A). F increases hyper-
bolically in the range 0–0.2 M glycerol, suggesting that ACP
binds glycerol. In the range 0–0.32 M glycerol, data fit well to





where KG is the dissociation constant of the enzyme-glycerol
complex, Fmax is the maximum value of F, and Gly-OH
indicates glycerol. This enables us to calculate a KG value of
17  1 mM.
The plot of kcat/Km against glycerol concentration (Fig. 1C)








where K is the size of the hyperbolic increase of kcat/Km due to
glycerol binding and KG indicates the dissociation constant of
the enzyme-glycerol complex, gives KG  15  4 mM, a value
close to that calculated from fluorescence.
To assess the effect of glycerol on kcat, we derived the overall
kcat of pNPP turnover from Scheme 1 (20, 21) as follows.
kcat 
k2k3  k4[Gly-OH])
k2  k3  k4[Gly-OH]
(Eq. 3)
When the rate-limiting step is the hydrolysis or alcoholysis of
E-P, Equation 3 can be reduced as follows.
kcat  k3  k4[Gly-OH] (Eq. 4)
Although the model described in Equation 4 indicates a linear
correlation between kcat and the concentration of glycerol, Fig.
1D shows that the data agree with a biphasic increase of kcat,
the initial phase (0–0.2 M glycerol) being hyperbolic and the





where k is the size of the hyperbolic increase of kcat caused by
glycerol binding, KG is the dissociation constant of the enzyme-
glycerol complex, and k4 is the rate constant for alcoholysis of
E-P (Scheme 1). From the kcat data we calculate a KG of 74  15
mM, a value that is about 5-fold higher than that calculated
from the data of fluorescence and kcat/Km. Considering that
kcat/Km is the apparent second-order constant for the reaction
of free enzyme and free substrate and that kcat is the first order
kinetic constant for the hydrolysis of the E-P covalent complex,
the difference in the value of KG indicates that the free enzyme
binds glycerol more strongly than the E-P complex does.
The second-order rate constant (k4) for phosphotransfer and
the E-P hydrolysis constant (k3) can be determined from Equa-
tion 5 (Fig. 1D). We found that k4  0.10  0.01 M
1s1 and
k3  0.11  0.01 s
1. The ratio of the rate of phosphotransfer
(k4) to the rate of hydrolysis (k3  k3/[H2O] (Scheme 1) is 50.5.
This value, compared with those of other phosphatases forming
E-P covalent intermediates in their catalytic pathways (21),
indicates a moderate tendency of ACP to catalyze
phosphotransfer.
The results of the fluorimetry experiments performed at low
glycerol concentration demonstrate that glycerol interacts with
the enzyme causing a hyperbolic increase of the overall activ-
ity. Nevertheless, at glycerol concentrations above 0.2 M, the
linear increase of activity agrees with the fact that alcoholysis
competes with hydrolysis for the E-P breakdown (Scheme 1).
Inorganic Phosphate-H2
18O Oxygen Exchange Experiments—
SCHEME 1. E, enzyme; R, aryl or acyl; ROH, phenol or carboxylic acid; Gly-OH, glycerol.
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Enzyme-catalyzed 18O exchange between Pi and water was
observed in a number of enzyme such as acid and alkaline
phosphatases, ATPases, low Mr phosphotyrosine protein phos-
phatase, and the catalytic domain of leukocyte antigen-related
phosphotyrosine protein phosphatase (Ref. 22 and citations
therein). All of these enzymes indeed form a phosphoenzyme in
their pathways. 18O exchange is therefore a convenient technique
for tracing E-P covalent complex formation in an enzymatic path-
way. Human CT-ACP is able to catalyze the inorganic phosphate-
H2
18O oxygen exchange reaction (Fig. 2). Experiments were per-
formed at 25 °C and pH 5.3. MS spectra of control samples to
which no enzyme was added confirm that the spontaneous ex-
change reaction was negligible (Fig. 2E). Fig. 2, A–C, shows the
MS spectra of the mixtures containing wild-type ACP measured
at 25, 49, and 76 h and demonstrates that the enzyme is able to
catalyze the time-dependent incorporation of 18O atoms into
phosphate when incubated with unlabeled Pi and H2
18O in the
absence of p-nitrophenol. All possible isotopomers are clearly
present after 76 h of incubation. Taking into account the preced-
ing results, we deduce that, in the presence of the enzyme and in
the absence of phenols, the inorganic phosphate-H2
18O oxygen
exchange can occur only if an E-P covalent intermediate is
formed and then hydrolyzed by cycling the two terminal steps in
the overall catalytic process shown in Scheme 2.
Fig. 2F illustrates the MS spectrum of an experiment per-
formed with alkaline phosphatase, an enzyme that forms an
E-P covalent intermediate in its catalytic pathway (23). This
experiment, which shows the rapid incorporation of all oxygen
isotopomers into phosphate, is a good control on the perform-
ance of the technique used here.
Structure-Activity Relationships—The initial rates for the
ACP-catalyzed hydrolysis of six aryl phosphates differing in the
leaving group pKa values (phenyl phosphate, 4-cyanophenyl
phosphate, 3-chlorophenyl phosphate, 4-nitrophenyl phosphate,
-naphthyl phosphate, and L-phosphotyrosine) were determined.
Measurements were performed at pH 5.3 and 37 °C using the
concentration range 0.05–3.2 mM for all substrates tested.
The Vmax and Km values were obtained by solving the
Michaelis-Menten equation v  Vmax [S]/(Km  [S]) by nonlin-
ear regression analysis with the aid of a computer program
(Fig. P, BioSoft). We examined the effect of the leaving group
TABLE I
Partition experiments with wild-type and H25Q mutant of CT acylphosphatase
Experiments were performed at 37 °C in 0.1 M sodium acetate buffer, pH 5.3, and 0.1 M sodium cacodylate buffer, pH 6.5. Reactions were started
by adding the appropriate amount of enzyme. At varying times, aliquots were withdrawn to assay, respectively, the released Pi and p NP for pNPP
experiments and Pi and benzoate for benzoyl phosphate experiments. R-OH indicates p-nitrophenol or benzoate released from pNPP or benzoyl
phosphate (B-P), respectively. wt, wild type. Experiments were performed with 2 mM B-P and 10 mM pNPP.
pH 5.3 pH 6.5
B-P wt pNPP wt pNPP H25Q B-P wt pNPP wt pNPP H25Q
Rate of R-OH productiona
in water 9816 0.567 0.103 2662 0.563 0.104
in 1 M glycerol 9369 1.166 0.142 2434 1.114 0.129
Rate of phosphate productiona
in water 9757 0.584 0.107 2656 0.602 0.101
in 1 M glycerol 9772 0.660 0.156 2518 0.565 0.126
Rate of phosphate transfera 0 0.506 0 0 0.549 0
[R-OH]/[phosphate]
in water 1.01 0.97 0.96 1.00 0.94 1.03
in 1 M glycerol 0.96 1.77 0.91 0.97 1.97 1.02
Transfer/hydrolysis ratio 0 0.77 0 0 0.97 0
a Values are expressed as mol/min/mg of protein.
FIG. 1. The effects of glycerol concentration on the fluores-
cence emission of human CT-ACP and on its main kinetic pa-
rameters. A, fluorescence emission spectra of human CT-ACP in the
absence and presence of glycerol. Spectra were acquired with a Shi-
madzu model RF-5000 spectrofluorimeter; the excitation wavelength
was 280 nm. Continuous line, without glycerol; dashed line, with 0.3 M
glycerol. The enzyme was dissolved in 0.1 M acetate buffer, pH 5.3,
containing 0.15 M NaCl. In B, the experimental points indicate the
relative difference of the fluorescence emission signal at 335 nm as a
function of glycerol concentration. C, plot of kcat/Km versus glycerol
concentration; D, plot of kcat versus glycerol concentration. The initial
rates of pNPP hydrolysis at the indicated glycerol concentrations were
determined at pH 5.3 and 37 °C.
FIG. 2. Electrospray MS-spectra from inorganic phosphate-
H2
18O oxygen exchange experiments. The panels show the intensi-
ties of ions relative to that of the H2P
16O4
 isotopomer, for which
intensity was fixed at 100%. The incubation times are indicated in the
panels. wt, wild type.
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pKa (pKa range, 7.14–10.07) on kcat and kcat/Km regarding the
aryl phosphatase activity of ACP (Brønsted correlation). These
free energy relationships provide information about the rate-
limiting step of the catalytic process and the nature of the
transition state. Fig. 3 shows the Brønsted plots that correlate,
respectively, kcat and kcat/Km values to the pKa values of the
substrate leaving group. The left side of this figure shows the
findings of earlier experiments on kcat and kcat/Km dependence
on the leaving group of seven acyl phosphates (24), whereas the
right side shows the results obtained here for kcat and kcat/Km
dependence on the leaving group pKa of six aryl phosphates.
For aryl phosphates, we found that the dependence of both log
kcat and log kcat/Km on the leaving group pKa are monophasic
(Fig. 3, right). By fitting the data to the linear equations
log kcat1gpKXOHconstant (Eq. 6)
or
log kcat/Km1gpKXOHconstant (Eq. 7)
where pK is the pKa of the leaving group XOH, we calculated,
respectively, the 1g values for kcat (–0.07  0.02) and kcat/Km
(– 0.20  0.11). The very small dependence of kcat and kcat/Km
on the leaving group pKa for aryl phosphates contrasts with the
strong dependence of kcat and kcat/Km on the leaving group pKa
for acyl phosphates (1g  1.38  0.14, and 1g  1.44 
0.22, respectively (see left side of Fig. 3, which shows data for
the strictly homologous bovine enzyme; taken from Paoli et al.
(24)). For aryl phosphates, the small dependence of kcat on the
structures of leaving group, which differ markedly in the pKa
(7.14 for 4-nitrophenyl phosphate and 10.07 for phosphoty-
rosine) indicates that the kcat values for various aryl phos-
phates are very close to each other, suggesting that a common
intermediate complex is formed and accumulated before the
limiting step of the catalytic process takes place. No such
accumulation of intermediate complex can be seen from the
data relative to the hydrolysis of acyl phosphates catalyzed by
the bovine CT-ACP (24), which is about 90% identical in se-
quence with the human CT acylphosphatase.
His-25 Is Involved in the Phosphotransfer and the Inorganic
Phosphate-H2
18O Oxygen Exchange Reactions Catalyzed by
ACP—Previous experiments have demonstrated that human
CT-ACP was inactivated by the Woodward reagent K, which
reacts specifically with His-25 located in the active site region,
even though the enzyme contains other histidine residues and
also several acidic residues that are potential targets for this
reagent (25). This finding revealed a very reactive nucleophile
in the active site region. We thus performed partition experi-
ments with the H25Q mutant of human CT-ACP in the pres-
ence and absence of 1 M glycerol. Table I shows that the muta-
tion of His-25 to Gln eliminates the enzyme capacity to catalyze
the phosphotransfer reaction. Interestingly, as observed in the
wild-type ACP, 1 M glycerol enhances the activity of the H25Q
mutant (by 	40% at pH 5.3 and 	25% at pH 6.5), suggesting
that the presence of glycerol also causes structural modifica-
tions to occur in this mutant. Furthermore, Fig. 2D shows that
the mutation of His-25 to Gln in ACP causes a strong decrease
in the catalytic rate of the inorganic phosphate-H2
18O oxygen
exchange reaction. Taken together, all of these results suggest
that His-25 is involved in the formation of an enzyme phospho-
histidine intermediate during the catalytic hydrolysis of pNPP.
DISCUSSION
Our results show evidence that human CT acylphosphatase
catalyzes the hydrolysis of aryl phosphate monoesters by a
mechanism that involves a nucleophilic catalysis step. On the
contrary, no nucleophilic catalysis occurs in the enzymatic hy-
drolysis of acyl phosphates. We obtained consistent proof of our
conclusions. First, the results obtained by kinetic experiments
performed at both pH 5.3 and 6.5 in the presence and absence
of glycerol suggest that an E-P covalent intermediate is formed
during the catalytic hydrolysis of pNPP but not of benzoyl
phosphate (see Table I). These findings also suggest that the
hydrolysis of E-P is the limiting step of pNPP hydrolysis by
CT-ACP. In fact, if the rate-limiting step is the formation of E-P
(Scheme 1) and the acceptor reacts with the intermediate after
the rate-limiting step, it does not increase the overall rate of
pNPP breakdown. Only if the rate-limiting step is the hydrol-
ysis of E-P, will the addition of the acceptor nucleophile in-
crease the breakdown of the intermediate and hence enhance
the overall reaction rate (14, 20). Furthermore, the results of
experiments performed at increasing glycerol concentrations
(range, 0.2–1 M) agree with the model described in Scheme 1
and Equation 4; this model assumes that an E-P covalent
intermediate is formed in the catalytic pathway of aryl phos-
phate hydrolysis. In the 0–0.2 M glycerol concentration range,
fluorescence spectroscopy shows that glycerol interacts with
the enzyme and enhances its activity (see Fig 1). We also
demonstrate that the mutation of His-25 to Gln completely
eliminates the capacity of the enzyme to catalyze the
transphosphorylation from pNPP to glycerol (Table I) demon-
strating that His-25 is involved in the nucleophilic catalysis
step.
The second proof derives from the results obtained by exper-
iments with inorganic phosphate-H2
18O oxygen exchange.
These also demonstrate that an E-P covalent intermediate is
FIG. 3. Effect of leaving group pKa on kcat and kcat/Km regard-
ing CT acylphosphatase. The lines were drawn using a linear regres-
sion method. Data for aryl phosphates are reported on the right; the
experimental points refer to 4-nitrophenyl phosphate (7.14), 4-cyano-
phenyl phosphate (7.95), 3-chlorophenyl phosphate (9.08), -naphtyl
phosphate (9.24), phenyl phosphate (9.99), and L-phosphotyrosine
(10.07). Data for acyl phosphates are shown on the left. The experimen-
tal points are taken from Paoli et al. (30) and refer to bovine CT-ACP,
which has about 90% sequence identity with respect to the human
enzyme. The pKa value for each leaving group is indicated in
parentheses.
SCHEME 2. The overall catalytic
pathway of aryl phosphate mo-
noester hydrolysis by human CT-
ACP. E, enzyme; Ar, aryl; P, phosphate
group.
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formed in the catalytic pathway (Fig. 2). Indeed, the inorganic
phosphate-H2
18O oxygen exchange can occur only if an E-P
covalent intermediate is formed and is hydrolyzed by cycling
the two terminal step in the overall catalytic process shown in
Scheme 2. The mutation of His-25 to Gln eliminates the capac-
ity of the enzyme to catalyze the inorganic phosphate-H2
18O
oxygen exchange (Fig. 2D), suggesting that a phosphohistidine
is involved in the process.
The third proof comes from the Brønsted free energy rela-
tionship experiments. For different aryl phosphates, the Brøn-
sted plot of kcat versus the leaving group pKa shows effectively
constant kcat values (Fig. 3, right), indicating that a common
intermediate is formed before the rate-limiting step of the
catalytic pathway (see Scheme 1). The slope of the curve is
slightly negative, giving a 1g value close to zero (–0.07). This
value indicates that a very low amount of negative charge
develops on the leaving group oxygen in the transition state. A
flat leaving group dependence suggests two hypotheses: either
the protonation of the leaving group occurs at the transition
state by general acid catalysis, or alternatively, the hydrolysis
step that leads to the release of phosphate is not rate-limiting.
The latter hypothesis is ruled out because CT-ACP is able to
catalyze transphosphorylation from pNPP to glycerol; only if
the E-P covalent complex (Scheme 1) accumulates before the
rate-limiting step can the addition of a nucleophile (glycerol)
competing with water increase the overall substrate break-
down (Table I).
In contrast with the results on aryl phosphates, previous
findings on acyl phosphates (24) have demonstrated that the
structure of the acyl group can have a dramatic effect on the
rate of CT-ACP catalysis (1g value of 1.38). The difference of
1.34 units of the leaving group pKa for acetyl phosphate (4.75)
and p-nitrobenzoyl phosphate (3.41) leads to a 50-fold enhance-
ment of kcat for p-nitrobenzoyl phosphate versus acetyl phos-
phate (24). Considering both substrate types (acyl phosphates
and aryl phosphates), a break in the leaving group dependence
(see Fig. 3) is usually attributed to a change in either the
mechanism or the rate-limiting step. The results of our exper-
iments support the former. Indeed, the earlier model for the
hydrolysis mechanism of acyl phosphates by CT-ACP, based on
x-ray crystallography data, does not include any step of nucleo-
philic catalysis (12). The mechanism proposed by Thunnissen
et al. (12) also agrees with our results because we observed no
transphosphorylation from benzoyl phosphate to glycerol, con-
sistent with the absence of any E-P covalent intermediate in
the catalytic pathway of acyl phosphate hydrolysis.
Collectively, all of our findings suggest that CT-ACP-cata-
lyzed hydrolyses of the two kinds of substrates follow two
different pathways (as shown in Scheme 3).
For acyl phosphates, a nucleophilic water molecule attacks
the Michaelis complex directly, producing Pi and the carboxy-
late anion. On the contrary, for aryl phosphates, the nucleo-
philic His-25 attacks the phosphorus atom of the substrate in
the Michaelis complex, phosphorylating the enzyme. The hy-
drolysis of the E-P covalent complex concludes the process and
is rate-limiting. The difference among the two mechanisms
could depend on the fact that the carboxylate anion is a better
leaving group than the phenolate anion. For acyl phosphates,
this may favor the formation of a strongly dissociative transi-
tion state in the limiting step (as indicated by the strong
dependence of kcat on the leaving group pKa; see Fig. 3, left),
which is efficiently stabilized by the active site environment.
This conclusion is supported by previous findings obtained for
the strictly homologous bovine CT-ACP (about 90% sequence
identity), which show that the formation of the transition state
during benzoyl phosphate hydrolysis is accompanied by a
strong reduction in the entropy of the hydrated enzyme-tran-
sition state complex compared with that of the hydrated en-
zyme-substrate Michaelis complex (24).
The binding of ACP to pNPP is not influenced by the H25Q
mutation; at pH 5.3 we found a Km  1.03  0.13 mM for the
mutant and a Km  1.10  0.04 mM for the wild-type enzyme.
In contrast, the binding of ACP to benzoyl phosphate is signif-
icantly affected by the His-25 mutation; at pH 5.3, we found Km
 0.55  0.03 mM for the mutant and Km  0.16  0.01 mM for
the wild-type enzyme. Furthermore, the mutation H25Q causes
a significant decrease in the specificity constant kcat/Km for
both pNPP and benzoyl phosphate. These findings indicate
that His-25 is involved in the catalysis of both kinds of sub-
strates, although the results reported in this study suggest that
this residue plays different roles in the two different pathways.
These and other findings, such as the observation that aryl
phosphates behave as competitive inhibitors with respect to
acyl phosphates (data not shown), collectively demonstrate
that the enzyme possesses a unique active site. The unusual
behavior of CT-ACP with regard to the mechanism of hydroly-
sis of two different kinds of substrates could be related to the
strongly different chemical properties of the leaving groups
(carboxylate and phenolate), which favor the formation of dif-
ferent transition states in the respective chemical steps of the
catalytic hydrolysis processes. Results from the Brønsted anal-
ysis of acylphosphatase-catalyzed reactions (Fig. 3) clearly in-
dicate a change in the nature of the transition state with a
change the nature of the substrates. We think that for acyl
phosphates, the intrinsic high stability of the carboxylate anion
leaving group in the transition state is the driving force of the
hydrolytic reaction, whereas for aryl phosphate monoesters a
proton must be donated to the leaving group in the transition
state for a productive forward reaction.
Previously, we demonstrated that Woodward’s reagent K
(N-ethyl-5-phenylisoxazolium-3-sulfonate) is able to form a
Michaelis-like complex with human CT-ACP and then inacti-
vate the enzyme modifying His-25 (25). Woodward’s reagent K
interacts with the substrate binding site by its sulfonic group
moiety, as suggested by the fact that some competitive inhibi-
tors elicit protective actions against inactivation. The chemical
modification of His-25 by Woodward’s reagent K is relatively
fast and highly specific, because other residues in the ACP
molecule were not modified (25). The fact that Woodward’s
reagent K, which behaves as a substrate-like compound, binds
to the CT-ACP active site and reacts easily with His-25 agrees
with the presence of this strongly reactive nucleophilic residue
SCHEME 3. Two different pathways
for acyl phosphate (top) and aryl
phosphate (bottom) hydrolysis by
ACP. E, enzyme; Ac, acyl; Ar, aryl; P,
phosphate group.
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in the active site environment. In fact, His-25 is very close to
Arg-23, an essential residue involved in substrate binding (12).
The cellular function of acylphosphatase is still under de-
bate. In our opinion, the most interesting results on the phys-
iological function of the enzyme in metazoan organisms are
those demonstrating its capability of uncoupling the membrane
ion pumps acting on the aspartyl phosphate intermediate
formed during their functions. Nevertheless, the enzyme seems
to be implicated in other processes such as differentiation and
apoptosis (4–6). Transient expression of ACP in cells induces
apoptosis (26), and thus it has been hitherto impossible to
obtain stable clones overexpressing the enzyme. An under-
standing of all of the aspects of the action mechanism of
acylphosphatase may help in the design and construction of
specific enzyme inhibitors useful for revealing the true sub-
strates of acylphosphatase in differing cell types and thus
toward discovering its function.
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